# Quality control and signaling pathways at stalled ribosomes

**Authors:** Weili Denyse Chang, Young-Jun Choe

PMC · DOI: 10.1038/s12276-025-01623-w · Experimental & Molecular Medicine · 2026-01-15

## TL;DR

This review explains how stalled ribosomes lead to faulty proteins and how cells manage these errors to prevent disease.

## Contribution

A comprehensive review of ribosome stalling mechanisms and their role in disease and cell signaling.

## Key findings

- Ribosome stalling leads to protein misfolding and activates quality control pathways.
- Defects in ribosome-associated quality control are linked to aging and neurodegenerative diseases.
- Understanding these mechanisms could lead to new treatments for protein misfolding diseases.

## Abstract

Aberrant mRNAs can arise from errors in RNA processing or from various physicochemical insults. Ribosomes translating such faulty mRNAs may stall, producing incomplete and potentially toxic polypeptides. These aberrant translation products are eliminated by the ribosome-associated quality control pathway. Ribosome stalling also leads to ribosome collisions, which can activate signaling pathways that enable cells to adapt to stress or determine cell fate. Here, in this Review, we summarize the molecular mechanisms of ribosome stalling and the associated quality control and signaling pathways, and discuss their implications in disease and therapeutics.

Proteins sometimes fold incorrectly, which can cause problems in cells. This Review explores how ribosomes can stall and lead to protein misfolding. The researchers review how ribosome stalling happens and how cells respond, focusing on a process called ribosome-associated quality control (RQC). RQC helps degrade faulty proteins and is crucial for maintaining cell health. The study explains that ribosome stalling can occur due to damaged RNA or specific sequences in the genetic code. Cells have mechanisms to resolve these stalls, such as splitting the ribosome into parts and degrading the faulty protein. Research highlights that defects in these processes are linked to aging and diseases such as neurodegeneration. The researchers conclude that understanding RQC better could lead to new treatments for diseases caused by protein misfolding. Future research may uncover more about how cells manage protein production and maintain health.

This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.

## Full-text entities

- **Genes:** HBS1 (ribosome dissociation factor GTPase HBS1) [NCBI Gene 853959], EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) [NCBI Gene 440275] {aka GCN2, PVOD2}, DOM34 (ribosome dissociation factor DOM34) [NCBI Gene 855731], Gtpbp1 (GTP binding protein 1) [NCBI Gene 14904] {aka GP-1, Gtpbp}, CBY1 (chibby 1, beta catenin antagonist) [NCBI Gene 25776] {aka C22orf2, CBY, Chibby1, HS508I15A, PGEA1, PIGEA-14}, RLI1 (Fe-S cluster-binding ribosome biosynthesis protein) [NCBI Gene 851665], PTRH1 (peptidyl-tRNA hydrolase 1 homolog) [NCBI Gene 138428] {aka C9orf115, PTH1}, VCP (valosin containing protein) [NCBI Gene 7415] {aka CDC48, FTDALS6, TERA, p97}, C9orf72 (C9orf72-SMCR8 complex subunit) [NCBI Gene 203228] {aka ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1}, GCN1 (GCN1 activator of EIF2AK4) [NCBI Gene 10985] {aka GCN1L, GCN1L1, PRIC295}, GIGYF2 (GRB10 interacting GYF protein 2) [NCBI Gene 26058] {aka GYF2, PARK11, PERQ2, PERQ3, TNRC15}, EIF4E (eukaryotic translation initiation factor 4E) [NCBI Gene 1977] {aka AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F, eIF-4E}, UBP2 (ubiquitin-specific protease UBP2) [NCBI Gene 854291], EEF2 (eukaryotic translation elongation factor 2) [NCBI Gene 1938] {aka EEF-2, EF-2, EF2, SCA26}, GCN2 (serine/threonine-protein kinase GCN2) [NCBI Gene 851877] {aka AAS1, AAS102, NDR2}, NEMF (nuclear export mediator factor) [NCBI Gene 9147] {aka IDDSAPN, NY-CO-1, RQC2, SDCCAG1}, ETF1 (eukaryotic translation termination factor 1) [NCBI Gene 2107] {aka D5S1995, ERF, ERF1, RF1, SUP45L1, TB3-1}, ANKZF1 (ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1) [NCBI Gene 55139] {aka Vms1, ZNF744}, HEL2 (E3 ubiquitin-protein ligase HEL2) [NCBI Gene 851859] {aka RQT1}, CAT (catalase) [NCBI Gene 847], EDF1 (endothelial differentiation related factor 1) [NCBI Gene 8721] {aka CFAP280, EDF-1, MBF1}, RKR1 (ubiquitin-protein ligase RKR1) [NCBI Gene 855289] {aka LTN1}, SEC61 (translocon subunit SEC61) [NCBI Gene 851095], CDC21 (thymidylate synthase) [NCBI Gene 854241] {aka CRT9, TMP1}, CUE3 (Cue3p) [NCBI Gene 852768] {aka RQT3}, RQC2 (Rqc2p) [NCBI Gene 856098] {aka TAE2}, LTN1 (listerin E3 ubiquitin protein ligase 1) [NCBI Gene 26046] {aka C21orf10, C21orf98, RNF160, ZNF294}, TRNT1 (tRNA nucleotidyl transferase 1) [NCBI Gene 51095] {aka CCA1, CGI-47, MtCCA, RPEM, SIFD}, ZNF598 (zinc finger protein 598, E3 ubiquitin ligase) [NCBI Gene 90850] {aka HEL2}, EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) [NCBI Gene 1915] {aka CCS-3, CCS3, EE1A1, EEF-1, EEF1A, EF-Tu}, Gtpbp2 (GTP binding protein 2) [NCBI Gene 56055] {aka nmf205}, GTPBP2 (GTP binding protein 2) [NCBI Gene 54676] {aka JABELS}, SLH1 (RNA helicase) [NCBI Gene 853187] {aka RQT2}, TrnI (tRNA-Ile) [NCBI Gene 17733], NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3) [NCBI Gene 4722] {aka CI-30, MC1DN8}, EIF4G1 (eukaryotic translation initiation factor 4 gamma 1) [NCBI Gene 1981] {aka EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18}, TRNG (tRNA-Gly) [NCBI Gene 4563] {aka MTTG}, TCF25 (TCF25 ribosome quality control complex subunit) [NCBI Gene 22980] {aka FKSG26, Hulp1, NULP1, PRO2620, hKIAA1049}, ABCE1 (ATP binding cassette subfamily E member 1) [NCBI Gene 6059] {aka ABC38, OABP, RLI, RLI1, RNASEL1, RNASELI}, UBP3 (mRNA-binding ubiquitin-specific protease UBP3) [NCBI Gene 856895] {aka BLM3}, EIF4E2 (eukaryotic translation initiation factor 4E family member 2) [NCBI Gene 9470] {aka 4E-LP, 4EHP, EIF4EL3, IF4e, h4EHP}
- **Diseases:** motor deficits (MESH:D009461), RQC (MESH:D007174), cognitive impairments (MESH:D003072), protein aggregation disorders (MESH:D066263), Huntington's disease (MESH:D006816), ALS (MESH:D000690), central nervous system (CNS) dysfunction (MESH:D002493), ISR (MESH:D000079225), intellectual disability (MESH:D008607), infection (MESH:D007239), Mitochondrial dysfunction (MESH:D028361), neurodegeneration (MESH:D019636), Cancer (MESH:D009369), FTD (MESH:D057180), motor (MESH:D000068079), juvenile neuromuscular disorders (MESH:D009468), cytotoxic (MESH:D064420), atrophy (MESH:D001284)
- **Chemicals:** polylysine (MESH:D011107), anisomycin (MESH:D000841), GDP (MESH:D006153), phosphate (MESH:D010710), Inosine (MESH:D007288), polyadenosine (MESH:C069424), Poly(A) (MESH:D011061), oxygen (MESH:D010100), threonine (MESH:D013912), aminoacyl-tRNAs (MESH:D012346), lysine (MESH:D008239), N6-methyladenosine (MESH:C010223), ATP (MESH:D000255), reactive oxygen species (MESH:D017382), m6A (MESH:C005955), alanine (MESH:D000409), Proline (MESH:D011392), alcohol (MESH:D000438), Aldehydes (MESH:D000447), HO (MESH:D017665), nucleotide (MESH:D009711), 5-FU (MESH:D005472), U (MESH:D014501), H2O2 (MESH:D006861), polyarginine (MESH:C015462), lipid (MESH:D008055), GTP (MESH:D006160), Superoxide (MESH:D013481), guanine (MESH:D006147), nitrosamines (MESH:D009602), nitrogen (MESH:D009584), Formaldehyde (MESH:D005557), adenosine (MESH:D000241), cyclic GMP-AMP (MESH:C584311), tryptophan (MESH:D014364), uracil (MESH:D014498), ENU (MESH:D005038), 8-oxo-7,8-dihydroguanine (MESH:C024829), poly(PA (-), Polytryptophan (MESH:C099320), N1-methylpseudouridine (MESH:C013608), CGA (MESH:C554042), polyglutamine (MESH:C097188), acetaldehyde (MESH:D000079), P (MESH:D010758)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227], Mus musculus (house mouse, species) [taxon 10090], Nicotiana tabacum (American tobacco, species) [taxon 4097], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Mutations:** R86S, R487G, Ala/Thr, A for CGA, termination at stop, G for CUG, A 60S

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12868832/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12868832/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12868832/full.md

---
Source: https://tomesphere.com/paper/PMC12868832